Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

In contrast, tests involving other cancer markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, generally cannot reach the high sensitivity needed for catching early-stage cancers.

The test – dubbed PAC-MANN – has been developed at Oregon Health and Science University A novel blood testing technique could ...

Researchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic cancer with 85% accuracy. Why it matters: Pancreatic cancer is often ...